Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM) and Ironwood Pharma (IRWD)

Tipranks - Tipranks - Tue Feb 24, 11:32AM CST

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Axsome Therapeutics (AXSM – Research Report) and Ironwood Pharma (IRWD – Research Report) with bullish sentiments.

Claim 50% Off TipRanks Premium

Axsome Therapeutics (AXSM)

TD Cowen analyst Joseph Thome maintained a Buy rating on Axsome Therapeutics today and set a price target of $215.00. The company’s shares closed last Monday at $173.76.

According to TipRanks.com, Thome is a 5-star analyst with an average return of 19.1% and a 59.6% success rate. Thome covers the Healthcare sector, focusing on stocks such as Rapport Therapeutics, Inc., Arrowhead Pharmaceuticals, and Viridian Therapeutics. ;'>

Axsome Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $212.08, which is a 20.2% upside from current levels. In a report issued on February 19, Mizuho Securities also maintained a Buy rating on the stock with a $230.00 price target.

See the top stocks recommended by analysts >>

Ironwood Pharma (IRWD)

In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Ironwood Pharma. The company’s shares closed last Monday at $3.80.

According to TipRanks.com, Knickerbocker is a 5-star analyst with an average return of 34.1% and a 59.1% success rate. Knickerbocker covers the Healthcare sector, focusing on stocks such as Phathom Pharmaceuticals, Diamedica Therapeutics, and Fennec Pharmaceuticals. ;'>

Ironwood Pharma has an analyst consensus of Moderate Buy, with a price target consensus of $6.50.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).